Portfolio company
Advanced Perfusion Diagnostics
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops single-use devices for non-invasive, continuous microcirculation assessment and early sepsis detection for clinicians in critical care and surgical settings.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
SepsiScan
This company develops bedside imaging devices for real-time microcirculation monitoring and early sepsis diagnosis for intensive care units and hospitals.
GlucoSet
The company develops an intravascular sensor that provides continuous blood glucose monitoring for critically ill patients in intensive care units.
Noninvasix
This company develops non-invasive optoacoustic monitoring technology to measure central venous oxygenation levels for clinicians treating patients with sepsis and septic shock.
FAST Biomedical
This company develops medical technology for measuring blood volume and kidney function to assist healthcare professionals treating heart failure and sepsis patients.
410 Medical
This company develops handheld rapid infusion devices to deliver fluids and blood to critically ill patients for hospitals and emergency medical services.
Sencilia
This company develops non-invasive flow sensors for monitoring intravenous infusion therapy in neonatal and paediatric intensive care units.
Novus Diagnostic
Novus Diagnostics develops point-of-care diagnostic devices for clinicians to detect and classify bloodstream infections, specifically sepsis, within fifteen minutes at the bedside.
Septest
This company develops point-of-need blood tests for healthcare professionals to rapidly identify infection and inflammation biomarkers in patients.
